The vision of the Snowdome Foundation is to ensure every Australian blood cancer
patient has the best opportunity for a cure, and this starts with a correct diagnosis.
We collaborate with world-leading Australian blood cancer researchers, both at home and overseas,
to accelerate new therapies and bring next-generation treatments to patients, faster.
We are the leading not-for-profit organisation focused exclusively on raising funds to
support translational research and clinical trials that will accelerate new treatments
(and cures) to help Australian blood cancer patients live longer, better lives.
Enabled more than $95 million to be invested in blood cancer research since 2010.
84 research projects funded enabling over 105 research positions.
Over 6,500 subsidised genomic tests completed at the Wilson Centre for Blood Cancer Genomics.
Enabled thousands of patients to participate in over 129 clinical trials.
Latest News
2026 John Tandy Myeloma Haematology Fellowship Announcement
Snowdome Foundation is proud to announce that Dr Kenneth Lim has been awarded the 2026 John Tandy Myeloma Haematology Fellowship. Named in honour of Dr John Tandy, whose myeloma diagnosis was one of the inspirations behind the establishment of Snowdome Foundation, the fellowship reflects Snowdome Foundation’s commitment to driving progress in blood cancer treatments. By … Continued
Read more
Twice Touched by Blood Cancer: The Livis Family’s story of Endurance and Progress
Twice, blood cancer has come for Lisa Livis’s family, and both times, research has met it with an answer. Lisa’s son Jason survived childhood leukaemia when a cure was far from guaranteed. Decades later, her husband Denis faced two separate blood cancers and ran out of standard options, only for new treatments to get him … Continued
Read more
Art of Innovation event
On Thursday, 27 August, Snowdome Foundation welcomed supporters, researchers and members of the Snowdome community to the National Gallery of Victoria for The Art of Innovation, an evening exploring the future of CAR T-cell therapy and the transformative potential of Australian research. Guests heard from leading experts Dr Sam Fiorenza and Professor Jane Oliaro, whose … Continued
Read more